Alnylam Ranks #1 in Boston Globe’s Top Places to Work List for 2021


CAMBRIDGE, Mass.– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it has ranked first in Boston Globe’s 2021 Top Places to Work in the “Largest Employer” category. This is the seventh consecutive year that Alnylam has been named a Top Place to Work by the Boston Globe and the first year that Alnylam has been eligible for the Largest Employer category (> 1,000 employees).

Companies named to the Top Places to Work list are chosen by the people who best understand the workplace environment, the employees. Employees complete an anonymous, research-backed survey assessing categories such as their company’s direction, execution, connection, management, work, pay and benefits. The list spotlights companies that support employees both in and out of the office, including caregiving, mental health, and other out-of-office needs. This recognition comes on the heels of Alnylam’s recent inclusion on Science Magazine’s Top Employer list for the third consecutive year.

“At Alnylam, we are changing the way disease is treated through the pursuit of innovative science, and that is only possible with a remarkable team,” said John Maraganore, Ph.D., Founding Chief Executive Officer of Alnylam. “Despite the ongoing challenges of 2021, our colleagues banded together to find creative ways to continue to innovate, collaborate, and deliver on behalf of the patients that depend on us. Our run of seven years in a row is a testament to that while our pioneering science is our foundation, our people are truly what makes Alnylam amazing.”